NexPhase Capital LP announced its investment in Magic Science Corporation on August 26, 2025, to support the company's expansion into product innovation, retail distribution, and development of category-defining consumer goods. The deal was advised by Raymond James and Skytale Group for the sell-side and Choate Hall & Stewart as legal counsel for NexPhase.

AcquirerNexPhase Capital LP
TargetMagic Science Corporation
Deal ValueUndisclosed
TypeInvestment
Closing Date2025-08-26
Sell-side AdvisorsRaymond James, Skytale Group
Buy-side AdvisorsNot disclosed
Legal Buy-SideChoate Hall & Stewart
Legal Sell-SideDickinson Wright

The strategic investment by NexPhase Capital is aimed at driving Magic Science Corporation’s growth in the healthcare sector through enhanced product development and distribution channels. This includes a focus on hypochlorous acid manufacturing, which positions Magic Science as a leader in antimicrobial solutions.